Search

Your search keyword '"Manica Balasegaram"' showing total 7 results
Start Over Author "Manica Balasegaram" Publisher elsevier bv
7 results on '"Manica Balasegaram"'

1. EQUITABLE ACCESS

Author

Manica Balasegaram and Jennifer Cohn

Subjects
Microbiology (medical), Infectious Diseases, General Medicine
Published
2023
Full Text
View/download PDF

2. Antimicrobial subscription and pooled procurement

Author

Manica, Balasegaram

Subjects
Viewpoint, Anti-Infective Agents, Humans, General Medicine, Anti-Bacterial Agents
Abstract

The COVID-19 pandemic has underlined the importance of an efficient and equitable supply of and access to essential health products. These factors are equally pertinent to the antimicrobial resistance pandemic, in which access to a portfolio of existing and pipeline antimicrobials plus complementary diagnostics is crucial. This Viewpoint focuses on market shaping in low-income and middle-income countries (LMICs), where the need for effective antimicrobials and complementary diagnostics is most acute. We propose the creation of a subscription and pooled procurement model that consolidates the growing demand for a portfolio of antimicrobials and diagnostics in LMICs. Anchored by regional market leaders, these pooling mechanisms would guarantee consistent private-sector and public-sector access in participating countries, while creating conditions for long-term best practice in stewardship. Supported by data from South Africa and India, this proposal sets out an innovative approach to tackle the antimicrobial resistance crisis in LMICs.

Published
2022
Full Text
View/download PDF

3. Analysis from the NeoOBS Global Neonatal Sepsis Prospective Observational Cohort Study Across 19 Hospitals in 11 Countries; Clinical Presentation, Treatment, Mortality Outcomes and Development of the NeoSEP Sepsis Severity Score

Author

Ruchi Nanavati, Julia Bielicki, Shamim Qazi, Liu Zunjie, Davide Bilardi, Nishad Plakkal, Ajay Dudeja, Surbhi Malhotra-Kumar, Daniel Jarovsky, Matthias Larsson, Mohammad Shahidul Islam, Madhusudhan Ds, Adrie Bekker, Manica Balasegaram, Suppawat Boonkasidecha, Cristina Gardonyi Carvalheiro, Sally Ellis, Sara Chiurchiù, Sithembiso Velaphi, Emmanuel Roilides, Trah Minh Dien, Herman Goossens, Tim R. Cressey, Yonghong Yang, Eitan Naaman Berezin, Christina W. Obiero, Tomislav Kostyanev, Jolly Nankunda, Sushma Nangia, Wolfgang Stöhr, Angela Dramowski, Kanchana Preedisripipat, Simon Cousens, Borna Nyaoke, Kosmas Sarafidis, Yijun Ding, Marisa Márcia Mussi-Pinhata, Jinxing Feng, Amy Riddell, Tanusha Ramdin, James A. Berkley, Maxensia Owor, Aislinn Cook, Reenu Thomas, Tuba Vilken, Mike Sharland, Ramesh Agarwal, Youri Glupczynski, Suman Chaurasia, Daynia E Ballot, Meera Khorona, Nathalie Khavessian, Sarah Walker, Neal Russell, Yajuan Wang, Wang Ping, Maia De Luca, Paul T. Heath, Samir K. Saha, and Bethou Adhisivam

Subjects
Carbapenem, medicine.medical_specialty, Research ethics, Neonatal sepsis, Proportional hazards model, business.industry, Birth weight, medicine.disease, Sepsis, Postnatal age, Emergency medicine, medicine, business, medicine.drug, Cohort study
Abstract

Background: Neonatal sepsis is associated with high mortality, but there is limited clinical data on outcomes in hospital facilities in low and middle income countries (LMIC). The NeoOBS study aimed to determine the clinical features, pathogens and clinical outcomes of infants presenting with neonatal sepsis in hospitals globally. Methods: Infants

Published
2021
Full Text
View/download PDF

4. Clinical Presentation and 28-Day Mortality in Hospitalized Neonates and Young Infants with Clinical Sepsis: The Global NeoOBS Observational Cohort

Author

Neal Russell, Wolfgang Stöhr, Nishad Plakkal, Aislinn Cook, James A. Berkley, Bethou Adhisivam, Ramesh Agarwal, Manica Balasegaram, Daynia Ballot, Adrie Bekker, Eitan Naaman Berezin, Davide Bilardi, Suppawat Boonkasidecha, Cristina G. Carvalheiro, Suman Chaurasia, Sara Chiurchiu, Simon Cousens, Tim R. Cressey, Trah Minh Dien, Yijun Ding, Angela Dramowski, Madhusudhan DS, Ajay Dudeja, Jinxing Feng, Youri Glupczynski, Herman Goossens, Mohammad Shahidul Islam, Daniel Jarovsky, Nathalie Khavessian, Meera Khorona, Tomislav Kostyanev, Matthias Larsson, Maia De Luca, Surbhi Malhotra-Kumar, Marisa M. Mussi-Pinhata, Ruchi Nanavati, Sushma Nangia, Jolly Nankunda, Borna Nyaoke, Christina W. Obiero, Maxensia Owor, Wang Ping, Kanchana Preedisripipat, Shamim Qazi, Tanusha Ramdin, Amy Riddell, Emmanuel Roilides, Samir Saha, Kosmas Sarafidis, Reenu Thomas, Sithembiso Christopher Velaphi, Tuba Vilken, Yajuan Wang, Yonghong Yang, Liu Zunjie, Sally Ellis, Julia Bielicki, Sarah Walker, Paul T. Heath, and Mike Sharland

Subjects
History, Polymers and Plastics, Business and International Management, Industrial and Manufacturing Engineering
Published
2021
Full Text
View/download PDF

5. Management of children with multidrug-resistant sepsis in low-income and middle-income countries

Author

Romain Basmaci, Manica Balasegaram, Julia Bielicki, Niranjan Kissoon, Mike Sharland, Ron Daniels, and Sally Ellis

Subjects
0301 basic medicine, medicine.medical_specialty, Poverty, business.industry, 030106 microbiology, MEDLINE, Low income and middle income countries, medicine.disease, Sepsis, 03 medical and health sciences, Environmental health, Pediatrics, Perinatology and Child Health, Developmental and Educational Psychology, Humans, Medicine, Child, business, Intensive care medicine
Published
2018
Full Text
View/download PDF

6. International cooperation to improve access to and sustain effectiveness of antimicrobials

Author

Didier Pittet, Richard D. Smith, Anna Zorzet, John-Arne Røttingen, Osman Dar, Jennifer Cohn, Abdul Ghafur, Nils Daulaire, Chantal M. Morel, Manica Balasegaram, Ramanan Laxminarayan, David L Heymann, Nisha Ranganathan, Kevin Outterson, Marc Mendelson, Mike Sharland, Luke S. P. Moore, Alison Holmes, Zain Rizvi, Christine Årdal, and Steven J. Hoffman

Subjects
0301 basic medicine, Infection Control/methods, Economic policy, International Cooperation, 030106 microbiology, Intellectual property, Collective action, Health Services Accessibility, 03 medical and health sciences, 0302 clinical medicine, Anti-Infective Agents, Political agenda, Anti-Infective Agents/supply & distribution/therapeutic use, Humans, Medicine, 030212 general & internal medicine, Health policy, ddc:616, Infection Control, business.industry, Health Policy, Environmental resource management, Drug Resistance, Microbial, General Medicine, Agriculture, Population Surveillance, Health law, business
Abstract

Securing access to effective antimicrobials is one of the greatest challenges today. Until now, efforts to address this issue have been isolated and uncoordinated, with little focus on sustainable and international solutions. Global collective action is necessary to improve access to life-saving antimicrobials, conserving them, and ensuring continued innovation. Access, conservation, and innovation are beneficial when achieved independently, but much more effective and sustainable if implemented in concert within and across countries. WHO alone will not be able to drive these actions. It will require a multisector response (including the health, agriculture, and veterinary sectors), global coordination, and financing mechanisms with sufficient mandates, authority, resources, and power. Fortunately, securing access to effective antimicrobials has finally gained a place on the global political agenda, and we call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action.

Published
2016
Full Text
View/download PDF

7. Twelve months outcome in kala-azar patients treated with 3 novel regimens, at public health care facilities in Bihar

Author

Nathalie Strub-Wourgaft, Temmy Sunyoto, Nines Lima, Bhawna Sharma, V.N. Rabi Das, Manica Balasegaram, Suman Rijal, Kusum Lata Pandey, Fabiana Alves, P. Das, Sakib Burza, Jorge Alvar, Raman Mahajan, Vishal Goyal, and Sally Ellis

Subjects
Microbiology (medical), medicine.medical_specialty, Pediatrics, Infectious Diseases, business.industry, Family medicine, medicine, General Medicine, business, Outcome (game theory), Public health care
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results